Castleman Disease with Renal Involvement: Case Series (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1273; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Case 1 demonstrated mild renal impairment with podocyte injury and stable CKD stage 3b following rituximab-based therapy...Case 4, a TAFRO phenotype, presented with thrombotic microangiopathy and acute kidney injury, achieving complete renal recovery after prompt corticosteroids and siltuximab...However, progression to chronic kidney disease may occur despite systemic remission, emphasizing the importance of early recognition and kidney biopsy. Histopathology appears to be a key determinant of prognosis, with inflammatory patterns showing reversibility, while chronic fibrosis predicts poorer outcomes."
Clinical • Acute Kidney Injury • Chronic Kidney Disease • Fibrosis • Focal Segmental Glomerulosclerosis • Glomerulonephritis • Immunology • Inflammation • Lupus Nephritis • Nephrology • Rare Diseases • Renal Disease
|
|
Lamis A. Almalki; Nina Teresa Weber; Abhijat Kitchlu; Harjot Singh Vohra; Rohan John
|